Mirum Pharmaceuticals, Inc

(NASDAQ:MIRM)

Latest On Mirum Pharmaceuticals, Inc (MIRM):

Date/Time Type Description Signal Details
2023-05-07 08:03 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) Q1 2023 Earnings Call TranscriptN/A
2023-05-05 03:10 ESTNewsMirum Pharmaceuticals Non-GAAP EPS of -$0.80 beats by $0.17, revenue of $31.6M beats by $0.81MN/A
2023-05-04 01:50 ESTNewsMirum Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-30 09:44 ESTNewsMirum Pharmaceuticals: Staying The CourseN/A
2023-04-13 08:06 ESTNewsMirum Pharmaceuticals prices notes worth $275MN/A
2023-04-12 19:36 ESTNewsMirum Pharmaceuticals reports preliminary unaudited financial results for Q1 2023N/A
2023-03-09 03:57 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) Q4 2022 Earnings Call TranscriptN/A
2023-02-14 11:04 ESTNewsMirum files for expanded approval of Livmarli in USN/A
2023-02-01 18:54 ESTNewsMirum Pharmaceuticals: In The Spotlight Following Buyout Of Albireo PharmaN/A
2022-11-29 09:10 ESTNewsMirum drops plans to develop liver disease candidate in pregnancyN/A
2022-11-20 19:55 ESTNewsMirum: Potential For European Approval To Move It ForwardN/A
2022-11-10 02:53 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 08:41 ESTNewsMirum Pharmaceuticals GAAP EPS of -$1.02 beats by $0.05, revenue of $18.78M misses by $2.03MN/A
2022-10-25 00:08 ESTNewsMirum says liver disease therapy met main goal in late-stage studyN/A
2022-10-14 19:50 ESTNewsMirum's liver disease drug Livmarli gets EMA committee nod for approval in EUN/A
2022-08-17 21:12 ESTNewsMirum: Great Sales Start For Livmarli Paves The Way For Long-Term GrowthN/A
2022-08-10 20:11 ESTNewsMirum Pharmaceuticals stock falls prices $80.0M stock offeringN/A
2022-08-10 02:57 ESTNewsMirum Pharmaceuticals falls aftermarket on $80M stock offeringN/A
2022-08-08 04:34 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 05:13 ESTNewsMirum Pharmaceuticals GAAP EPS of -$0.84 beats by $0.31, revenue of $17.5M beats by $2.08MN/A
2022-08-03 23:16 ESTNewsMirum Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-05-27 23:11 ESTNewsMirum Pharmaceuticals: Post-Approval Execution Looks ExcellentN/A
2022-05-24 00:37 ESTNewsMirum acquires San Diego-based Satiogen in stock and cash combinationN/A
2022-05-08 01:25 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-07 04:44 ESTNewsMirum Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 05:07 ESTNewsMirum Pharmaceuticals GAAP EPS of -$1.17 beats by $0.23, revenue of $12.89M beats by $4.43MN/A
2022-03-10 02:23 ESTNewsMirum Pharmaceuticals reports Q4 resultsN/A
2022-03-10 02:23 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-09 09:31 ESTNewsMirum Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-12 01:19 ESTNewsMirum Pharmaceuticals grants stock options under inducement planN/A
2021-12-17 06:35 ESTNewsMirum Pharmaceuticals Gets The 'Thumbs Up'N/A
2021-12-15 14:30 ESTNewsMirum Pharmaceuticals to join NASDAQ Biotechnology IndexN/A
2021-11-17 21:27 ESTNewsMirum Pharmaceuticals to sell Rare Pediatric Disease PRV for $110MN/A
2021-11-16 04:18 ESTNewsMirum Pharmaceuticals reports Q3 resultsN/A
2021-11-16 04:18 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 04:18 ESTNewsMirum Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-12 04:54 ESTNewsMirum Pharmaceuticals: Livmarli Approval Could Spark A Bull Run For This Young BiotechN/A
2021-10-27 22:00 ESTNewsWarning: MIRM is at high risk of performing badlyN/A
2021-09-29 19:13 ESTNewsFDA approves Mirum Pharmaceuticals' Alagille syndrome treatment LivmarliN/A
2021-09-22 00:37 ESTNewsMirum Pharmaceuticals (MIRM) Investor Presentation - SlideshowN/A
2021-09-22 00:24 ESTNewsMirum submits application to EMA for maralixibat in Alagille SyndromeN/A
2021-09-22 00:12 ESTNewsMirum and Takeda ink exclusive licensing agreement to commercialize maralixibat in JapanN/A
2021-08-25 00:56 ESTNewsMirum And Maralixibat In Pediatric Cholestasis: The DifferentiationN/A
2021-08-08 15:26 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 06:42 ESTNewsMirum Pharmaceuticals beats on revenueN/A
2021-07-27 13:01 ESTNewsMirum Pharma inks maralixibat development deal for rare liver disease in South KoreaN/A
2021-07-21 15:36 ESTNewsMirum Is Undervalued Despite Expected Tough CompetitionN/A
2021-07-21 15:35 ESTNewsMirum Pharmaceuticals highlights maralixibat liver disease data analysesN/A
2021-07-21 15:34 ESTNewsMirum adds veteran biotechnology executive Carol Brosgart to board of directorsN/A
2021-07-21 15:27 ESTNewsAnalysis shows safety of Mirum's maralixibat for liver disorder maintained over five yearsN/A

About Mirum Pharmaceuticals, Inc (MIRM):

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company was incorporated in 2018 and is headquartered in Foster City, California.

See Advanced Chart

General

  • Name Mirum Pharmaceuticals, Inc
  • Symbol MIRM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 68
  • Fiscal Year EndDecember
  • IPO Date2019-07-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.mirumpharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 4.53
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.56
  • Next Year EPS Estimate -$2.39
  • Next Quarter EPS Estimate -$0.64
  • Return on Assets -34%
  • Return on Equity -68%
  • Earnings Per Share -$28.94
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 610.52 million
  • PE Ratio -18.84
  • Analyst Target Price $50.29
  • Book Value Per Share $6.48
View More

Share Statistics

  • Shares Outstanding 30.42 million
  • Shares Float 12.19 million
  • % Held by Insiders 909%
  • % Held by Institutions 70.89%
  • Shares Short 674051
  • Shares Short Prior Month 637658
  • Short Ratio 5.61
  • Short % of Float 4%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • 52 Week High $27.43
  • 52 Week Low $10.14
  • 50 Day Moving Average 19.23
  • 200 Day Moving Average 19.6
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Mirum Pharmaceuticals, Inc (MIRM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Mirum Pharmaceuticals, Inc (MIRM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$N/A-$1.43-$0.98-45.49%
2020-09-302020-11-12$N/A-$0.86-$0.9812.46%
2020-06-302020-08-06$N/A-$0.93-$0.87-6.5%
2020-03-312020-05-07$N/A-$0.86-$0.84-2.83%
2019-12-312020-03-12$N/A-$0.79-$0.856.73%
2019-09-302019-11-06$N/A-$0.84-$0.63-34.14%
2019-06-302019-08-28$N/A-$0.59-$0.590.47%

Mirum Pharmaceuticals, Inc (MIRM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Mirum Pharmaceuticals, Inc (MIRM) Chart:

Mirum Pharmaceuticals, Inc (MIRM) News:

Below you will find a list of latest news for Mirum Pharmaceuticals, Inc (MIRM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Mirum Pharmaceuticals, Inc (MIRM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-19300CALL0 0324.88TRUE00
2025-09-19350CALL0 0276.75TRUE00
2025-09-19400CALL0 0253.78TRUE00
2025-09-19450CALL0 0215.28TRUE00
2025-09-19500CALL0 0180.63TRUE00
2025-09-19556.05CALL0 4148.78TRUE00
2025-09-19603.55CALL0 69116.67TRUE00
2025-09-19659CALL0 14626.24TRUE00
2025-09-19705.5CALL2 10445.78TRUE-1.3-0.19
2025-09-19752CALL1 1035.25FALSE20
2025-09-19800.52CALL3 8433.62FALSE-0.43-0.45
2025-09-19300PUT0 0348.15FALSE00
2025-09-19350PUT0 0297.58FALSE00
2025-09-19400PUT0 0254.23FALSE00
2025-09-19451.25PUT0 27216.05FALSE00
2025-09-19500PUT0 091.94FALSE00
2025-09-19550.32PUT0 4149.94FALSE00
2025-09-19600PUT0 0120.12FALSE00
2025-09-19652.36PUT0 248.75FALSE00
2025-09-19700.9PUT106 235.66FALSE-0.1-0.1
2025-09-19753.5PUT2 343.01TRUE10.4
2025-09-19800PUT0 036.81TRUE00
2025-10-17200CALL0 0313.62TRUE00
2025-10-1722.50CALL0 0286.45TRUE00
2025-10-17250CALL0 0262.72TRUE00
2025-10-17300CALL0 0222.69TRUE00
2025-10-173519CALL0 11189.62TRUE00
2025-10-17400CALL0 0161.34TRUE00
2025-10-17454.5CALL0 1253.6TRUE00
2025-10-175010.7CALL0 0114.18TRUE00
2025-10-17553.71CALL0 1431.32TRUE00
2025-10-176015.3CALL0 8435.84TRUE00
2025-10-17650CALL0 233.99TRUE00
2025-10-17707.6CALL0 645.4TRUE00
2025-10-17750CALL0 232.25FALSE00
2025-10-17802CALL0 11942.91FALSE00
2025-10-17850.9CALL0 11441.42FALSE00
2025-10-17200PUT0 0186.85FALSE00
2025-10-1722.50PUT0 0288.26FALSE00
2025-10-17250PUT0 0264.88FALSE00
2025-10-17300PUT0 1225.41FALSE00
2025-10-17350PUT0 0192.76FALSE00
2025-10-17400PUT0 1164.77FALSE00
2025-10-17450PUT0 8140.12FALSE00
2025-10-17507.6PUT0 6117.91FALSE00
2025-10-17550PUT0 097.47FALSE00
2025-10-17603.7PUT0 078.24FALSE00
2025-10-17650PUT0 059.65FALSE00
2025-10-17702.65PUT0 440.83FALSE00
2025-10-17750PUT0 032.41TRUE00
2025-10-17800PUT0 032.38TRUE00
2025-10-17850PUT0 037.62TRUE00
2025-12-19150CALL0 0253.15TRUE00
2025-12-1917.50CALL0 0227.5TRUE00
2025-12-19200CALL0 0203.4TRUE00
2025-12-1922.50CALL0 0185.38TRUE00
2025-12-19250CALL0 266.32TRUE00
2025-12-19300CALL0 0143.12TRUE00
2025-12-19350CALL0 4121.24TRUE00
2025-12-194012CALL0 4454.71TRUE00
2025-12-19459.5CALL0 293.16TRUE00
2025-12-195024.6CALL5 4835.3TRUE24.60
2025-12-19554.45CALL0 440.05TRUE00
2025-12-19607.6CALL0 2641.63TRUE00
2025-12-19658.09CALL0 18837.88TRUE00
2025-12-19700CALL0 036.29TRUE00
2025-12-19756.37CALL0 834.65FALSE00
2025-12-19802.9CALL0 1036.59FALSE00
2025-12-19852.6CALL0 1035.95FALSE00
2025-12-19900CALL0 034.67FALSE00
2025-12-19950CALL0 050.06FALSE00
2025-12-19150PUT0 0144.3FALSE00
2025-12-1917.50PUT0 0228.72FALSE00
2025-12-19200PUT0 1113.94FALSE00
2025-12-1922.50.1PUT0 498.32FALSE00
2025-12-19250PUT0 1165.76FALSE00
2025-12-19300PUT0 2141.08FALSE00
2025-12-19350PUT0 2120.61FALSE00
2025-12-19401.65PUT0 989109.25FALSE00
2025-12-19450PUT0 987.55FALSE00
2025-12-19505.4PUT0 678.45FALSE00
2025-12-19555.1PUT0 265.02FALSE00
2025-12-19600PUT0 052.41FALSE00
2025-12-19650PUT0 041.03FALSE00
2025-12-19700PUT0 038.33FALSE00
2025-12-197511.2PUT0 535.59TRUE00
2025-12-19800PUT0 036.77TRUE00
2025-12-19850PUT0 035.75TRUE00
2025-12-19900PUT0 036.82TRUE00
2025-12-19950PUT0 040.39TRUE00
2026-01-1622.50CALL0 070.89TRUE00
2026-01-162535.5CALL0 2152.41TRUE00
2026-01-16300CALL0 067.6TRUE00
2026-01-16350CALL0 054.02TRUE00
2026-01-16400CALL0 097.25TRUE00
2026-01-16450CALL0 044.97TRUE00
2026-01-165012.8CALL0 3638.97TRUE00
2026-01-165511CALL0 038.85TRUE00
2026-01-166014.4CALL0 2039.57TRUE00
2026-01-16658.87CALL0 436.8TRUE00
2026-01-16705.6CALL0 3837.65TRUE00
2026-01-16754.46CALL0 12735.05FALSE00
2026-01-16805.4CALL0 1039.61FALSE00
2026-01-16850CALL0 035.6FALSE00
2026-01-16900CALL0 039.47FALSE00
2026-01-16950CALL0 044.39FALSE00
2026-01-1622.50PUT0 0170.65FALSE00
2026-01-16250PUT0 0156.89FALSE00
2026-01-16300PUT0 0133.66FALSE00
2026-01-16351.3PUT0 166.42FALSE00
2026-01-16400PUT0 098FALSE00
2026-01-16455PUT0 283.51FALSE00
2026-01-16500PUT0 070.47FALSE00
2026-01-16553.5PUT0 1058.48FALSE00
2026-01-16603.8PUT0 247.22FALSE00
2026-01-16650PUT0 038.15FALSE00
2026-01-16700PUT0 037.72FALSE00
2026-01-16750PUT0 035.99TRUE00
2026-01-16800PUT0 036.43TRUE00
2026-01-16850PUT0 036.1TRUE00
2026-01-16900PUT0 037.92TRUE00
2026-01-16950PUT0 037.32TRUE00
2026-04-17350CALL0 049.98TRUE00
2026-04-17400CALL0 050.82TRUE00
2026-04-17450CALL0 043.15TRUE00
2026-04-17500CALL0 043.18TRUE00
2026-04-17550CALL0 040.53TRUE00
2026-04-17600CALL0 041.41TRUE00
2026-04-176511.07CALL0 8040.01TRUE00
2026-04-177012.7CALL0 039.48TRUE00
2026-04-17750CALL0 038.21FALSE00
2026-04-17805.25CALL0 12839.3FALSE00
2026-04-17854.7CALL0 137.69FALSE00
2026-04-17900CALL0 038.92FALSE00
2026-04-17950CALL0 039.6FALSE00
2026-04-171002.7CALL0 139.33FALSE00
2026-04-171052.05CALL0 141.71FALSE00
2026-04-17350PUT0 055.44FALSE00
2026-04-17400PUT0 076.99FALSE00
2026-04-17450PUT0 065.73FALSE00
2026-04-17500PUT0 055.6FALSE00
2026-04-17550PUT0 046.29FALSE00
2026-04-17605.2PUT0 141.52FALSE00
2026-04-17650PUT0 038.91FALSE00
2026-04-17700PUT0 037.26FALSE00
2026-04-17750PUT0 037.05TRUE00
2026-04-17800PUT0 037.24TRUE00
2026-04-17850PUT0 037.36TRUE00
2026-04-17900PUT0 037.4TRUE00
2026-04-17950PUT0 037.09TRUE00
2026-04-171000PUT0 037.58TRUE00
2026-04-171050PUT0 037.12TRUE00

Latest MIRM Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST4$20.27
Jun 13, 2022 7:59 PM EST34$20.26
Jun 13, 2022 7:59 PM EST50$20.26
Jun 13, 2022 7:59 PM EST50$20.26
Jun 13, 2022 7:59 PM EST100$20.24

Mirum Pharmaceuticals, Inc (MIRM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm
2019-06-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000019010501/0000000000-19-010501-index.htm
2019-07-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000019010921/0000000000-19-010921-index.htm
2019-12-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000019016859/0000000000-19-016859-index.htm
2020-08-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000020007237/0000000000-20-007237-index.htm
2019-12-27DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1759425/000095012319012069/0000950123-19-012069-index.htm
2019-07-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000107261319000249/0001072613-19-000249-index.htm
2019-12-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000117266119002410/0001172661-19-002410-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000117266120000737/0001172661-20-000737-index.htm
2019-06-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519184371/0001193125-19-184371-index.htm
2019-07-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000119312519189959/0001193125-19-189959-index.htm
2019-07-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519189965/0001193125-19-189965-index.htm
2019-07-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000119312519193277/0001193125-19-193277-index.htm
2019-07-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519193289/0001193125-19-193289-index.htm
2019-07-158-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1759425/000119312519194022/0001193125-19-194022-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519194112/0001193125-19-194112-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519194115/0001193125-19-194115-index.htm
2019-07-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1759425/000119312519196500/0001193125-19-196500-index.htm
2019-07-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312519200063/0001193125-19-200063-index.htm
2019-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312519202499/0001193125-19-202499-index.htm
2019-07-26SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312519204056/0001193125-19-204056-index.htm
2019-08-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312519210092/0001193125-19-210092-index.htm
2019-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312519232419/0001193125-19-232419-index.htm
2019-08-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759425/000119312519232544/0001193125-19-232544-index.htm
2019-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312519324949/0001193125-19-324949-index.htm
2020-01-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000119312520002291/0001193125-20-002291-index.htm
2020-01-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312520002347/0001193125-20-002347-index.htm
2020-01-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312520002352/0001193125-20-002352-index.htm
2020-01-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1759425/000119312520004784/0001193125-20-004784-index.htm
2020-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312520007165/0001193125-20-007165-index.htm
2020-01-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312520009903/0001193125-20-009903-index.htm
2020-04-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312520126318/0001193125-20-126318-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000119380519000651/0001193805-19-000651-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-07-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000119380519000662/0001193805-19-000662-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000119380520000192/0001193805-20-000192-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042429/0001209191-19-042429-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042433/0001209191-19-042433-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042435/0001209191-19-042435-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042437/0001209191-19-042437-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042439/0001209191-19-042439-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042441/0001209191-19-042441-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042442/0001209191-19-042442-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042445/0001209191-19-042445-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042446/0001209191-19-042446-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042447/0001209191-19-042447-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042448/0001209191-19-042448-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042449/0001209191-19-042449-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042451/0001209191-19-042451-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042453/0001209191-19-042453-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042454/0001209191-19-042454-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042455/0001209191-19-042455-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042456/0001209191-19-042456-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042457/0001209191-19-042457-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042458/0001209191-19-042458-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042460/0001209191-19-042460-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042470/0001209191-19-042470-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042476/0001209191-19-042476-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042479/0001209191-19-042479-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042482/0001209191-19-042482-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042486/0001209191-19-042486-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042489/0001209191-19-042489-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042657/0001209191-19-042657-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043021/0001209191-19-043021-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm
2019-10-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119054233/0001209191-19-054233-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119054240/0001209191-19-054240-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120000307/0001209191-20-000307-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003335/0001209191-20-003335-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003338/0001209191-20-003338-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003342/0001209191-20-003342-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003345/0001209191-20-003345-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003348/0001209191-20-003348-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2020-04-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120026416/0001209191-20-026416-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120026418/0001209191-20-026418-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036572/0001209191-20-036572-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036581/0001209191-20-036581-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036587/0001209191-20-036587-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036594/0001209191-20-036594-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036597/0001209191-20-036597-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036618/0001209191-20-036618-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm
2019-07-16CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1759425/000135445719000353/0001354457-19-000353-index.htm
2019-09-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000139506419000029/0001395064-19-000029-index.htm
2019-08-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459019033345/0001564590-19-033345-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459019040998/0001564590-19-040998-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459019041030/0001564590-19-041030-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020010454/0001564590-20-010454-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1759425/000156459020010471/0001564590-20-010471-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1759425/000156459020019713/0001564590-20-019713-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1759425/000156459020019725/0001564590-20-019725-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020022831/0001564590-20-022831-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459020022856/0001564590-20-022856-index.htm
2020-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759425/000156459020023010/0001564590-20-023010-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm
2020-08-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000156459020035305/0001564590-20-035305-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020037717/0001564590-20-037717-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459020037771/0001564590-20-037771-index.htm
2020-08-10S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000156459020038927/0001564590-20-038927-index.htm
2019-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759425/999999999519001627/9999999995-19-001627-index.htm
2020-01-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759425/999999999520000041/9999999995-20-000041-index.htm
2020-08-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759425/999999999520002122/9999999995-20-002122-index.htm
2019-07-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1759425/999999999719006082/9999999997-19-006082-index.htm

Mirum Pharmaceuticals, Inc (MIRM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mirum Pharmaceuticals, Inc (MIRM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 909%
Institutional Ownership: 7089%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-10Laura BregeDirectorBuy10,000.0011.22112,200.0010,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm
2019-09-06Pamela VigChief Scientific OfficerBuy1,600.0010.9617,539.201,600.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-09-06Pamela VigChief Scientific OfficerBuy12.0011.88142.561,612.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-07-22James E Flynn10% Share HolderBuy166,000.0015.002,490,000.00166,000.00https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-09-06Laurent FischerDirectorBuy1,720.0010.7118,429.281,720.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-07-22James E Flynn10% Share HolderBuy166,000.0015.002,490,000.001,724,456.00https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-09-06Ian ClementsSVP Finance & CommunicationsBuy1,801.0011.0719,937.071,801.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-07-22Niall O'DonnellDirectorBuy300,000.0015.004,500,000.001,921,118.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm
2019-09-06Christopher PeetzPresident and CEOBuy4,750.0010.9151,805.88192,250.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-09Christopher PeetzPresident and CEOBuy2,000.0010.9021,800.00194,250.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-09Christopher PeetzPresident and CEOBuy2,320.0011.3526,332.00196,570.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-07-22Holdings A/S Novo10% Share HolderBuy575,000.0015.008,625,000.002,445,147.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm
2020-10-30Edwin Jonathan TuckerChief Medical OfficerBuy25,000.007.70192,500.0031,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm
2019-09-09Laurent FischerDirectorBuy1,670.0010.5417,601.803,390.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2020-03-19Edwin Jonathan TuckerChief Medical OfficerBuy2,000.009.9119,818.003,500.00https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2019-07-22Frazier Life Sciences IX, L.P.10% Share HolderBuy450,000.0015.006,750,000.003,566,912.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm
2019-07-22Patrick J HeronDirectorBuy450,000.0015.006,750,000.003,566,912.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm
2019-09-09Laurent FischerDirectorBuy300.0011.303,390.003,690.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-06Ian ClementsSVP Finance & CommunicationsBuy2,199.0011.8726,102.134,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-07-22Ali Behbahani10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm
2019-07-22Anthony A. Jr. Florence10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm
2019-07-22Carmen Chang10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm
2019-07-22DAVID M MOTT10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm
2019-07-22FOREST BASKETT10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm
2019-07-22JOSHUA MAKOWER10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm
2019-07-22Mohamad Makhzoumi10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm
2019-07-22New Enterprise Associates 16, L.P.10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm
2019-07-22Paul Edward Walker10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm
2019-07-22PETER J BARRIS10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm
2019-07-22Peter W. Sonsini10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm
2019-07-22SCOTT D SANDELL10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm
2019-09-10Laurent FischerDirectorBuy960.0010.299,881.474,650.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-16Laurent FischerDirectorBuy452.009.474,280.445,102.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm
2020-03-20Edwin Jonathan TuckerChief Medical OfficerBuy2,500.0011.9029,740.006,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2019-09-17Laurent FischerDirectorBuy1,648.009.3715,435.176,750.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm